Journal references for ZMC's
HIV p24 Antigen ELISA Kit
Baba M, Takashima K, Miyake H,
et al.
TAK-652 Inhibits CCR5-Mediated Human Immunodeficiency Virus Type
1 Infection In Vitro and Has Favorable Pharmacokinetics in
Humans. Antimicrob Agents Chemother. 2005; 49 (11):
4584-4591.
Bemelmans AP, Kostic C, Crippa
SV, et al.
Lentiviral Gene Transfer of Rpe65 Rescues Survival and Function
of Cones in a Mouse Model of Leber Congenital Amaurosis.
PLoS Med. 2006; 3 (10): e347.
Blancou P, Evans DT, Desrosiers
RC.
PRA1 co-localizes with envelope but does not influence primate
lentivirus production, infectivity or envelope incorporation.
Journal of General Virology. 2005; 86: 1785-1790.
Caceda R, Kinkead B, Owens M, et
al.
Virally Mediated Increased Neurotensin 1 Receptor in the Nucleus
Accumbens Decreases Behavioral Effects of Mesolimbic System
Activation. The Journal of Neuroscience. 2005; 25
(50): 11748-11756.
Emori Y, Ikeda T, Ohashi T, et
al.
Inhibition of human immunodeficiency virus type 1 replication by
Z-100, an immunomodulator extracted from human-type tubercle
bacilli, in macrophages. J Gen Virology. 2004; 85:
2603-2613.
Fang J, Kubota S, Pomerantz RJ.
A Trans-Dominant Negative HIV Type 1 Rev with Intact Domains of
NLS/NOS and NES. AIDS Research and Human Retroviruses.
2002; 18 (10): 705-709.
Finnegan CM, Rawat SS, Puri A,
et al.
Ceramide, a target for antiretroviral therapy. Proc Natl
Acad Sci U S A. 2004; 101 (43): 15452-15457.
Forthal DN, Landucci G, Daar ES.
Antibody from Patients with Acute Human Immunodeficiency Virus
(HIV) Infection Inhibits Primary Strains of HIV Type 1 in the
Presence of Natural-Killer Effector Cells. J Virol.
2001; 75 (15): 6953-6961.
Forthal DN, Landucci G, Phan TB,
et al.
Interactions between Natural Killer Cells and Antibody Fc Result
in Enhanced Antibody Neutralization of Human Immunodeficiency
Virus Type 1. J Virol. 2005; 79 (4): 2042-2049
Hamer DH, Bocklandt S, McHugh L,
et al.
Rational Design of Drugs That Induce Human Immunodeficiency
Virus Replication. J Virol. 2003; 77 (19):
10227-10236.
Ikeda T, Nishitsuji H, Zhou X,
et al.
Evaluation of the Functional Involvement of Human
Immunodeficiency Virus Type 1 Integrase in Nuclear Import of
Viral cDNA during Acute Infection. J Virol . 2004;
78 (21): 11563-11573.
Jiang YH, Emau P, Cairns S, et
al.
SPL7013 Gel as a Topical Microbicide for Prevention of Vaginal
Transmission of SHIV89.6P in Macaques. AIDS Research and
Human Retroviruses. 2005; 21 (3): 207-213.
Kamada K, Igarashi T, Martin MA,
et al.
Generation of HIV-1 derivatives that productively infect macaque
monkey lymphoid cells. Proc Natl Acad Sci U S A.
2006; 103 (45): 16959-16964.
Kameoka M, Nukuzuma S, Itaya A,
et al.
RNA Interference Directed against Poly(ADP-Ribose) Polymerase 1
Efficiently Suppresses Human Immunodeficiency Virus Type 1
Replication in Human Cells. J Virol. 2004; 78 (16):
8931-8934.
Kawano Y, Yoshida T, Hieda K, et
al.
A Lentiviral cDNA Library Employing Lambda Recombination Used To
Clone an Inhibitor of Human Immunodeficiency Virus Type
1-Induced Cell Death. J Virol. 2004; 78 (20):
11352-11359.
Kino T, Gragerov A, Slobodskaya
O, et al.
Human Immunodeficiency Virus Type 1 (HIV-1) Accessory Protein
Vpr Induces Transcription of the HIV-1 and
Glucocorticoid-Responsive Promoters by Binding Directly to
p300/CBP Coactivators. J Virol. 2002; 76 (19):
9724-9734.
Kobayashi M, Takaori-Kondo A,
Shindo K, et al.
APOBEC3G Targets Specific Virus Species. J Virol.
2004; 78 (15): 8238-8244.
Komoto S, Tsuji S, Ibrahim MS,
et al.
The Vpu Protein of Human Immunodeficiency Virus Type 1 Plays a
Protective Role against Virus-Induced Apoptosis in Primary CD4 +
T Lymphocytes. J Virol. 2003; 77 (19): 10304-10313.
Lawrence DMP, Durham LC,
Schwartz L, et al.
Human Immunodeficiency Virus Type 1 Infection of Human
Brain-Derived Progenitor Cells. J Virol. 2004; 78
(14): 7319-7328.
Marodon G, Klatzmann D.
In situ transduction of stromal cells and thymocytes upon
intrathymic injection of lentiviral vectors. BMC
Immunology. 2004; 5: 18.
McGettigan JP, Naper K,
Orenstein J, et al.
Functional Human Immunodeficiency Virus Type 1 (HIV-1) Gag-Pol
or HIV-1 Gag-Pol and Env Expressed from a Single
Rhabdovirus-Based Vaccine Vector Genome. J Virol.
2003; 77 (20): 10889-10899.
McGettigan JP, Pomerantz RJ,
Siler CA, et al.
Second-Generation Rabies Virus-Based Vaccine Vectors Expressing
Human Immunodeficiency Virus Type 1 Gag Have Greatly Reduced
Pathogenicity but Are Highly Immunogenic. J Virol.
2003; 77 (1): 237-244.
McGettigan JP, Sarma S,
Orenstein JM, et al.
Expression and Immunogenicity of Human Immunodeficiency Virus
Type 1 Gag Expressed by a Replication-Competent
Rhabdovirus-Based Vaccine Vector. J Virol. 2001; 75
(18): 8724-8732.
Miyauchi K, Komano J, Yokomaku
Y, et al.
Role of the Specific Amino Acid Sequence of the
Membrane-Spanning Domain of Human Immunodeficiency Virus Type 1
in Membrane Fusion. J Virol. 2005; 79 (8):
4720-4729.
Nishikawa M, Takashima K, Nishi
T, et al.
Analysis of Binding Sites for the New Small-Molecule CCR5
Antagonist TAK-220 on Human CCR5. Antimicrob Agents
Chemother. 2005; 49 (11): 4708-4715.
Nishitsuji H, Kohara M, Kannagi
M, et al.
Effective Suppression of Human Immunodeficiency Virus Type 1
through a Combination of Short- or Long-Hairpin RNAs Targeting
Essential Sequences for Retroviral Integration. J Virol.
2006; 80 (15): 7658-7666.
Nitanda T, Wang X, Kumamoto H,
et al.
Anti-Human Immunodeficiency Virus Type 1 Activity and Resistance
Profile of 2',3'-Didehydro-3'-Deoxy-4'-Ethynylthymidine In
Vitro. Antimicrob Agents Chemother. 2005; 49 (8):
3355-3360.
Oruetxebarria I, Venturini F,
Kekarainen, et al.
p 16INK4a Is Required for hSNF5 Chromatin Remodeler-induced
Cellular Senescence in Malignant Rhabdoid Tumor Cells.
J. Biol. Chem. 2004; 279 (5): 3807-3816.
Sakuragi J, Iwamoto A, Shioda T.
Dissociation of Genome Dimerization from Packaging Functions and
Virion Maturation of Human Immunodeficiency Virus Type 1.
Journal of Virology. 2002; 76 (3): 959-967.
Sakuragi J, Ueda S, Iwamoto A,
et al.
Possible Role of Dimerization in Human Immunodeficiency Virus
Type 1 Genome RNA Packaging. J Virol. 2003; 77 (7):
4060-4069.
Shoya Y, Tokunaga K, Sawa H, et
al.
Human topoisomerase I promotes HIV-1 proviral DNA synthesis:
Implications for the species specificity and cellular tropism of
HIV-1 infection. PNAS. 2003; 100 (14): 8442-8447.
Smulevitch S, Michalowski D,
Zolotukhin AS, et al.
Structural and Functional Analysis of the RNA Transport Element,
a Member of an Extensive Family Present in the Mouse Genome.
J Virol. 2005; 79 (4): 2356-2365.
Takashima K, Miyake H, Furuta
RA, et al.
Inhibitory Effects of Small-Molecule CCR5 Antagonists on Human
Immunodeficiency Virus Type 1 Envelope-Mediated Membrane Fusion
and Viral Replication. Antimicrob Agents Chemother.
2001; 45 (12): 3538-3543.
Takashima K, Miyake H, Kanzaki
N, et al.
Highly Potent Inhibition of Human Immunodeficiency Virus Type 1
Replication by TAK-220, an Orally Bioavailable Small-Molecule
CCR5 Antagonist. Antimicrob Agents Chemother. 2005;
49 (8): 3474-3482.
Tomiyama H, Akari H, Adachi A,
et al.
Different Effects of Nef-Mediated HLA Class I Down-Regulation on
Human Immunodeficiency Virus Type 1-Specific CD8 + T-Cell
Cytolytic Activity and Cytokine Production. J Virol.
2002; 76 (15): 7535-7543.
Trushin SA, Bren GD, Asin S, et
al.
Human Immunodeficiency Virus Reactivation by Phorbol Esters or
T-Cell Receptor Ligation Requires both PKCα and PKCθ.
J Virol. 2005; 79 (15): 9821-9830.
Yokomaku Y, Miura H, Tomiyama H,
et al.
Impaired Processing and Presentation of Cytotoxic-T-Lymphocyte
(CTL) Epitopes Are Major Escape Mechanisms from CTL Immune
Pressure in Human Immunodeficiency Virus Type 1 Infection.
J Virol. 2004; 78 (3): 1324-1332.
Yonezawa A, Morita R,
Takaori-Kondo A, et al.
Natural Alpha Interferon-Producing Cells Respond to Human
Immunodeficiency Virus Type 1 with Alpha Interferon Production
and Maturation into Dendritic Cells. J Virol. 2003;
77 (6): 3777-3784.
Valentin A, Rosati M, Patenaude
DJ, et al.
Persistent HIV-1 infection of natural killer cells in patients
receiving highly active antiretroviral therapy. Proc
Natl Acad Sci U S A. 2002; 99 (10): 7015-7020.
Zhang C, Chen Y, Ben K.
An improved microtiter assay for evaluating anti-HIV-1
neutralizing antibodies from sera or plasma. BMC Infect
Dis. 2003; 3: 30.
Zhang XY, La Russa VF,
Jakob Reiser J.
Transduction of Bone-Marrow-Derived Mesenchymal Stem Cells by
Using Lentivirus Vectors Pseudotyped with Modified RD114
Envelope Glycoproteins. J Virol. 2004; 78 (3):
1219-1229.
|